hiCare 3.0 embeds Indie Health’s remote device pairing function to facilitate ease of use for patients, physicians
SAN DIEGO and BOSTON, October, 11, 2018 – Hifinite, which designs, develops and deploys customized digital health platforms, announced today the launch of Hifinite’s hiCare 3.0 telehealth and remote monitoring platform in partnership with Indie Health. Indie will supply its blood pressure monitor and weight scale, optimized for ease-of-use, as part of the hiCare 3.0 solution. Indie’s proprietary AutoPair™ function enables its personal health devices to be paired remotely by experts, eliminating the need for patients or clinicians to manage device set up and facilitating easy patient onboarding for digital health programs.
“hiCare 3.0 represents an even more user-friendly platform for telehealth and integrates our patented approach to deliver H.O.P.E. —highly optimized patient engagement—via digital health,” said Matt Weisensee, Chief Commercial Officer, Hifinite. “We are delighted to partner with Indie Health, which shares our objective to simplify patient engagement.” “Indie Health is focused on solving the challenges of integrating digital health into clinician workflow and the daily lives of patients, and we're pleased to be working together with Hifinite to realize this vision,” said Clint McClellan, Founder and Chief Executive Officer of Indie Health.
“By enabling Indie devices to be paired to an app remotely, AutoPair removes a significant barrier to physician and patient adoption, and enables rapid scale-up of digital health programs, with no delays or hassles.”
From conception to execution, hiCare 3.0 is an integrated telehealth “Module as a Service” solution built to ease patient/payer use and offers instantaneous access to a comprehensive digital ecosystem and technology stack via standalone or integrated modules. The company’s hiCare 3.0 platform is fully integrated with Android, iOS, WebOS, and supports Alexa and Google Home Voice Recognition.
Hifinite will exhibit at the 10th annual Connected Health Conference (“CHC18”), taking place
October 17-19 at the Boston Seaport World Trade Center, where the company is launching the hiCare 3.0 telehealth and remote medical monitoring system. The company's range of products and services will be featured at Hifinite's Booth (403/304).
Indie Health's Founder and Chief Executive Officer, Clint McClellan, will present on the main
agenda panel session “What it Really Takes to Build a Connected Health Solution” on Friday, October 19 (12:40-1:30 p.m.), and will deliver a presentation in the CHC18 Startup Showcase on the exhibit floor, “Advice from a Tech Veteran” Thursday, October 18 (11:50 a.m. – 12:05 p.m.). Indie Health is a Bronze sponsor of CHC18.
About Indie Health
Indie Health makes digital health accessible, easy and reliable, offering a digital health device portfolio optimized for patients, healthcare providers, platform solution providers and value added resellers. Indie Health eliminates technology barriers with its one-of-a-kind, proprietary AutoPair™ feature. AutoPair reduces complications, with factory-built standardization, rigorous device testing and optimization of device profiles for rapid, native app integration. Indie’s devices are IoT-ready and are integrated into leading digital health platforms. Make digital health accessible at www.indie-health.com.
About Hifinite Health
Hifinite is an innovative digital health company that designs, develops and deploys customized healthcare platforms to engage, consult, educate and remotely monitor patients, payers, providers and patients alike. Founded in Southern California’s “MedComm”
valley, Hifinite delivers leading edge healthcare technology of the future, today. By creating
white-labeled health & wellness apps, and software solutions, it helps patients and clinical
research participants live happier, healthier lives. hCare assists with data management,
mitigating risk, while saving time, money and lives. For more information on Hifinite and to stay up to date on the latest news, visit www.hifinite.com.
Comments